Skip to main content

Table 1 Baseline characteristics among patients with and without adverse outcomes

From: Developing a scoring tool to estimate the risk of deterioration for normotensive patients with acute pulmonary embolism on admission

 

All patients

Adverse outcomes

p-value

(n = 845)

Yes (n = 81)

No (n = 764)

Sex (male)

420 (49.7%)

42(51.9%)

378 (49.5%)

0.68

Age (years)

60.05 ± 15.43

59.36 ± 15.74

60.12 ± 15.40

0.93

Heart rate (beats/min)

86.57 ± 17.81

108.64 ± 22.84

84.23 ± 15.45

 < 0.001

Systolic pressure (mmHg)

124.33 ± 18.26

115.22 ± 19.64

125.30 ± 17.85

 < 0.001

RV dysfunction

240(28.4%)

59(72.8%)

181(23.7%)

 < 0.001

c-Tn I (μg/L)

0.11 ± 0.47

0.25 ± 0.49

0.091 ± 0.46

 < 0.001

NT-pro BNP (pg/mL)

1,547.12 ± 3,652.06

131,039 ± 3,255.93

3,779.92 ± 5,832.71

 < 0.001

CPA embolism

209 (24.7%)

45 (55.6%)

164 (22.0%)

 < 0.001

Saddle-CPA embolism

62 (7.3%)

17 (21.0%)

45 (5.9%)

 < 0.001

RV short-axis diameter (mm)

39.21 ± 7.42

44.70 ± 8.53

38.62 ± 7.05

 < 0.001

LV short-axis diameter (mm)

40.76 ± 7.30

33.68 ± 6.91

41.51 ± 6.94

 < 0.001

RV4-chamber diameter (mm)

36.38 ± 7.37

42.64 ± 10.28

35.72 ± 6.67

 < 0.001

LV 4-chamber diameter (mm)

39.47 ± 7.36

31.63 ± 7.09

40.30 ± 6.88

 < 0.001

RA 4-chamber diameter (mm)

45.44 ± 9.34

52.38 ± 11.72

44.70 ± 8.74

 < 0.001

LA 4-chamber diameter (mm)

34.83 ± 8.52

29.18 ± 8.00

35.43 ± 8.35

 < 0.001

RV/LV short-axis diameter ratio

1.00 ± 0.30

1.38 ± 0.40

0.96 ± 0.25

 < 0.001

RV/LV 4-chamber diameter ratio

0.96 ± 0.31

1.44 ± 0.59

0.90 ± 0.20

 < 0.001

RA/LA 4-chamber diameter ratio

1.39 ± 0.52

1.97 ± 0.87

1.33 ± 0.42

 < 0.001

Bova score

 Low risk

681 (75.9%)

33 (40.7%)

648 (84.4%)

 < 0.001

 Intermediate-low risk

102 (12.1%)

17 (20.7%)

85 (11.1%)

0.009

 Intermediate-high risk

62 (7.3%)

31 (38.3%)

31 (4.1%)

 < 0.001

2019 ESC algorithm

 Low risk

503 (59.5%)

17 (21.0%)

486 (63.6%)

 < 0.001

 Intermediate-low risk

172 (20.4%)

14 (17.3%)

158 (20.7%)

0.47

 Intermediate-high risk

170 (20.1%)

50 (61.7%)

120 (15.7%)

 < 0.001

  1. c Tn-I cardiac troponin I, NT-pro BNP N-terminal pro-brain natriuretic peptide, CPA central pulmonary artery, RV right ventricle, LV left ventricle, RA right atrium, LA left atrium, ESC European Society of Cardiology